SEC Form 4 · accession 0001209191-18-045962
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John R Beaver
Officer — EVP & Chief Financial Officer
Period of report
Aug 7, 2018
Accepted (ET)
Aug 9, 2018 · 10:54 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.20 | Aug 7, 2018 | A | 60,000 | A | — | Aug 7, 2028 | Common Stock | 60,000 | 760,000 | D |
Explanation of responses
- F1The stock option vests as to 30,000 shares, on August 7, 2019, and as to 30,000 shares, on August 7, 2020, subject to Mr. Beaver's continued service.